Rockefeller Capital Management
SBRA icon

Rockefeller Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Rockefeller Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Sell
19,636
-785
-4% -$15.6K ﹤0.01% 2231
2026
Q1 		$393K Buy
20,421
+3,747
+22% +$73.8K ﹤0.01% 2114
2025
Q4 		$316K Buy
16,674
+2,378
+17% +$44.1K ﹤0.01% 2131
2025
Q3 		$266K Buy
14,296
+316
+2% +$5.9K ﹤0.01% 2075
2025
Q2 		$258K Buy
13,980
+345
+3% +$6.12K ﹤0.01% 1676
2025
Q1 		$238K Sell
13,635
-3,255
-19% -$54.9K ﹤0.01% 1630
2024
Q4 		$293K Buy
16,890
+1,521
+10% +$27.8K ﹤0.01% 1601
2024
Q3 		$286K Buy
15,369
+655
+4% +$11K ﹤0.01% 1547
2024
Q2 		$227K Buy
14,714
+511
+4% +$7.3K ﹤0.01% 1607
2024
Q1 		$210K Sell
14,203
-471
-3% -$6.52K ﹤0.01% 1655
2023
Q4 		$209K Buy
+14,674
New +$208K ﹤0.01% 1529
2023
Q3 		– Sell
-11,719
Closed -$138K – 1770
2023
Q2 		$138K Buy
11,719
+188
+2% +$2.14K ﹤0.01% 1734
2023
Q1 		$132K Buy
11,531
+3
+0% +$37 ﹤0.01% 1871
2022
Q4 		$143K Sell
11,528
-183,329
-94% -$2.34M ﹤0.01% 1834
2022
Q3 		$2.56M Buy
194,857
+180,101
+1,221% +$2.66M 0.01% 691
2022
Q2 		$206K Buy
14,756
+3,115
+27% +$41.6K ﹤0.01% 1628
2022
Q1 		$173K Buy
11,641
+11,478
+7,042% +$157K ﹤0.01% 1745
2021
Q4 		$2K Sell
163
-40
-20% -$566 ﹤0.01% 3566
2021
Q3 		$3K Buy
203
+18
+10% +$304 ﹤0.01% 3359
2021
Q2 		$3K Sell
185
-6
-3% -$107 ﹤0.01% 3187
2021
Q1 		$3K Buy
191
+79
+71% +$1.39K ﹤0.01% 3045
2020
Q4 		$1K Sell
112
-20,115
-99% -$321K ﹤0.01% 2774
2020
Q3 		$278K Sell
20,227
-259
-1% -$3.8K ﹤0.01% 951
2020
Q2 		$296K Buy
20,486
+34
+0.2% +$447 ﹤0.01% 849
2020
Q1 		$223K Buy
20,452
+275
+1% +$5.07K ﹤0.01% 789
2019
Q4 		$431K Buy
20,177
+20,000
+11,299% +$448K 0.01% 611
2019
Q3 		$4K Buy
+177
New +$3.77K ﹤0.01% 1693
2019
Q2 		– Sell
-763
Closed -$15K – 1924
2019
Q1 		$15K Buy
+763
New +$14.5K ﹤0.01% 1365

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rockefeller Capital Management's SBRA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 3.8% in Q2 2026, selling an estimated $15.6K and leaving 19,636 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Rockefeller Capital Management first reported a position in SBRA in Q1 2019 and has held it in 28 quarters since. The position peaked at $2.56M in Q3 2022. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Rockefeller Capital Management held 19,636 shares of Sabra Healthcare REIT worth $383K as of Q2 2026.
  • Rockefeller Capital Management sold 785 Sabra Healthcare REIT shares in Q2 2026, an estimated $15.6K.
  • Sabra Healthcare REIT made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2231 holding.
  • Rockefeller Capital Management first reported a position in Sabra Healthcare REIT in Q1 2019 and has held it in 28 quarters since.
  • Rockefeller Capital Management's Sabra Healthcare REIT position peaked at $2.56M in Q3 2022.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.